glp 1 metabolic boost drops fda approved Compounded GLP-1s: Why doctors worry and the is cracking down FDA is moving to restrict

GLP-1s are an approved treatment for those with a BMI over 30, or a BMI over 27 with at least one comorbidity like type 2 diabetes, hypertension or sleep apnea

In a sense, the research suggests GLP-1s may be working almost too well in some patients, lowering blood pressure more than expected

This mechanism is particularly beneficial in conditions characterized by excessive or thickened mucus, [35] such as chronic obstructive pulmonary disease (COPD), cystic fibrosis, rhinitis or sinusitis

ElSayed NA, et al

But for people who currently use medications like Wegovy and Ozempic for weight loss, you may face one of the following issues that have become common across the U.S

Nat Med 28 , 20832091 (2022)